Loading...

PRCT - PROCEPT BioRobotics Corporation

Analyst Coverage Initiated Signal for 06-23-2022
Analyst Coverage Initiated: PRCT rating Buy by B. Riley Securities
Price Target: $53



Stock Signal Information


Signal

Analyst Coverage Initiated Stock
Report Date: 06-23-2022
Symbol: PRCT - PROCEPT BioRobotics Corporation
Sector: Healthcare
Industry: Medical Devices
Analyst Coverage Initiated: PRCT rating Buy by B. Riley Securities
Price Target: $53

  PRCT Technical Chart

Company Contact

PROCEPT BioRobotics Corporation (PRCT)
900 Island Drive
Redwood City, CA
Phone: 650 232 7200
Website: http://www.procept-biorobotics.com
CEO:


Company Profile

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is based in Redwood City, California.